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Abstract
A common feature in the maturation of linear dsDNA viruses is that the lengthy viral genome is translocated with remarkable velocity
into a limited space within a preformed protein shell using ATP as motor energy. Most biomotors, such as myosin, kinesin, DNA-helicase,
and RNA polymerase, contain one ATP-binding component that acts processively. An examination of the well-studied dsDNA viruses
reveals that DNA packaging motors involve two nonstructural components. Which component of the motor is the integrated processive
factor to turn the motor has not been identified. In bacterial virus phi29, these two components consist of a gp16 protein and an RNA
molecule called pRNA. We have previously predicted and recently confirmed that gp16 binds ATP. It is generally believed that gp16 serves
as an ATP-binding and processive component to drive the motor. In this article, phi29 DNA-packaging intermediates were purified in
quantity and examined to differentiate the role between gp16 and pRNA. It was found that the pRNA hexamer is an integral motor
component, while gp16 is not stably bound. Only one pRNA hexamer, but multiple copies of gp16, were needed to accomplish DNA
packaging. pRNA functions continuously during the entire DNA translocation process, suggesting that pRNA is a vital part of the DNA
packaging motor.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Extensive investigation on the assembly of dsDNA vi-
ruses documents a common feature: the lengthy viral ge-
nome is translocated quite rapidly into a confined area
inside a preformed protein shell and packaged into a near
crystalline density. This energetically unfavorable DNA
packaging reaction is accomplished by a viral DNA pack-
aging motor (Black, 1989; Earnshaw and Casjens, 1980;
Guo, 1994). ATP hydrolysis supplies the energy to drive
this otherwise unfavorable motion reaction. One ATP is
needed to package two base pairs of DNA (Guo et al., 1987;
Morita et al., 1993). An examination of dsDNA viruses
reveals that DNA packaging motors involve two nonstruc-
tural components, at least one being a typical ATPase. In
bacterial virus phi29, the two components are a protein,
gp16, and an RNA, pRNA.
Bacterial virus phi29 is an ideal system for the study of
the mechanism of DNA packaging due to its high efficiency
of in vitro DNA packaging (Guo et al., 1986). All compo-
nents needed to package phi29 DNA and to assemble in-
fectious virions have been purified. The in vitro assembly
system can convert a DNA-filled capsid into an infectious
virion. With this efficient system, up to 109 PFU/ml of
infectious virions can be assembled in vitro, while the omis-
sion of a single component results in no plaque formation
(Lee and Guo, 1995). Thus, there is a system with eight
orders of sensitivity for the analysis of the structure and
function of each component, and for the elucidation of how
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the DNA-packaging motor functions. The structure of the
connector, one of the components of the DNA packaging
motor, has been solved by X-ray crystallography (Guasch et
al., 2002; Simpson et al., 2000). The phi29 DNA packaging
motor has been reported to be the strongest motor studied to
date, with a stalling force of more than 50 pN and an initial
speed of 100 bases per second under external load (Smith et
al., 2001). The pRNA has been shown to form a hexamer
that gears the DNA-packaging motor (Guo et al., 1998;
Hendrix, 1998; Trottier and Guo, 1997; Zhang et al., 1998).
A computer model of the pRNA hexamer and the motor
complex has been presented (Hoeprich and Guo, 2002).
To ensure continuous motion of a motor, at least one
component should act processively or continuously. Most
motor proteins, including myosin (Inoue et al., 2002; Rom-
berg and Vale, 1993), kinesin (Hackney, 1995; Schnitzer
and Block, 1997), DNA-helicase (Pang et al., 2002; West,
1996), RNA polymerase (Harada et al., 2001; Wirtz et al.,
1998), and the T7 DNA-ejection motor (Molineux, 2001),
involve one component that acts processively. Increasing
evidence suggests that viral DNA-packaging motors are
similar in some respects to DNA or RNA processing, riding,
or sliding enzymes such as DNA-helicase, RNA polymer-
ase, and the RNA transcription termination factor Rho (Guo
et al., 1998; for review, see Guo, 2002). DNA-packaging
components are apparently required to act continuously
during DNA translocation. For example, the use of certain
temperature-sensitive mutants of T4 terminase can lead to
cessation of DNA packaging and production of partially
filled procapsids (Wunderli et al., 1977). Continuous action
of -terminase is required for packaging (Becker et al.,
1977). However, which component of the phi29 DNA pack-
aging motor acts continuously has not been previously dem-
onstrated; gp16 and pRNA are possible candidates. It is
shown here that pRNA is the integral component in the
phi29 DNA-packaging motor. This finding was made pos-
sible by a new approach that allowed for the isolation of
higher quantities of phi29 DNA packaging intermediates.
Results
Isolation of DNA-packaging intermediates
Assembly of the infectious phi29 virion in vitro includes
two steps: DNA packaging and virion maturation. Due to
the rapidity of the DNA-packaging process, it has been very
difficult to elucidate intermediates. Isolation of intermedi-
ates in quantity for biological assays has not been reported
previously due to the lack of a sensitive method to identify
them. However, with the aid of the highly sensitive phi29 in
vitro assembly system, these intermediates have now been
isolated.
Phi29 DNA packaging was performed in a mixture con-
taining procapsid, gp16, pRNA, genomic DNA-gp3, ATP,
and magnesium ion. The poorly hydrolyzable ATP ana-
logue -S-ATP was used to block the DNA packaging for
the isolation of phi29 DNA-packaging intermediates. When
-S-ATP was present, DNA packaging was incomplete and
part of the genome extended from the procapsid. The inter-
mediates were separated from finished DNA-filled capsids,
empty procapsids, or free DNA by sucrose gradient sedi-
mentation. The finished DNA-filled capsids centered at
fraction 8 of the gradient (Fig. 1), while smaller or lighter
particles, such as free DNA, stayed near the top of the
gradient. After sedimentation, the finished DNA-filled cap-
sids and the DNA packaging intermediates in each fraction
of the gradient were converted into matured infectious
phi29 virions through the addition of maturation compo-
nents (Fig. 1). When -S-ATP was not added into the
DNA-packaging mixture, few DNA-packaged intermedi-
ates were detected. However, when 5% of the ATP was
replaced by -S-ATP, DNA-packaging intermediates with
slower sedimentation rates were produced (Fig. 1).
Requirement of gp16 and pRNA for the formation of DNA
packaging intermediates
The aforementioned isolation method of DNA-packag-
ing intermediates was used to find out which components
were necessary for the formation of DNA-packaging inter-
mediates. After sucrose gradient sedimentation, DNA pack-
aging intermediates were converted into infectious phi29
virion by the addition of the maturation components (Fig.
2). It was found that both gp16 and pRNA were needed for
the formation of the intermediates. If either gp16 or pRNA
was omitted from the assembly mixture, no finished DNA-
Fig. 1. Use of the poorly hydrolysable ATP analogue -S-ATP to produce
DNA-packaging intermediates. After DNA packaging, the intermediates
were separated from free DNA and the finished DNA-filled procapsids by
5–20% sucrose gradient. The intermediates in each fraction of the gradient
were subsequently converted into infectious phi29 virion, expressed as
plaque-forming unit per milliliter (PFU/ml) by the addition of components
required for phi29 maturation. Sedimentation is from right to left (see
Materials and methods).
109D. Shu, P. Guo / Virology 309 (2003) 108–113
filled capsids or DNA-packaging intermediates were pro-
duced (Fig. 2).
Requirement of fresh gp16 for maturation of the
intermediates
Isolated DNA-packaging intermediates were tested to
find out which components are needed to complete the
packaging process. ATP, gp16, and pRNA were added
individually, or in combination, with maturation proteins
into each fraction of a gradient that had separated filled
capsids from intermediates. This procedure allows infec-
tious virions to be made from filled capsids without further
addition of gp16 or pRNA (Fig. 3). Conversion of the
intermediates to filled capsids required adding gp16 (Fig.
3B). However, intermediates contained the necessary pRNA
and no additional pRNA was needed to convert them into
infections virion (Fig. 3A), indicating that the bound pRNA
is sufficient for the continuation of the genome packaging.
Continuous function of pRNA during DNA translocation
It has been reported previously that six pRNA molecules
bind to the motor as a hexamer (Guo et al., 1998; Hendrix,
1998; Trottier and Guo, 1997; Zhang et al., 1998). As
already noted, it is not necessary to add fresh pRNA to
convert the intermediates into infectious virions (Fig. 3A).
To test whether the procapsid-bound pRNA was needed
during DNA translocation, RNase was added to cleave the
motor-bound pRNA. It was found that after RNase treat-
ment, the DNA-packaging intermediates could not be con-
verted into infectious virions, while RNase did not affect the
conversion of the finished DNA-filled capsid into an infec-
tious virion (Fig. 3C). This shows that continued function of
pRNA is needed for DNA translocation.
Discussion
Careful scrutiny of dsDNA viruses reveals a common
feature that their DNA packaging motors involve two non-
structural components with at least one of them having
characteristics of typical ATPases. A comparison among the
nonstructural DNA-packaging proteins of the well-studied
Fig. 2. Conversion of DNA-packaging intermediates into mature virions to
demonstrate the requirement of pRNA and gp16 for the initiation of DNA
packaging. “Omit gp16” or “Omit pRNA” indicates that during the first
DNA packaging step, gp16 or pRNA, respectively, was omitted from the
DNA packaging mixture. “Complete” indicates the inclusion of all com-
ponents needed in the first DNA-packaging step. The components in each
fraction of all gradients were subsequently converted into infectious phi29
virion by the addition of maturation components.
Fig. 3. Requirement of fresh gp16 and ATP but no requirement of pRNA
for the completion of DNA packaging in intermediates. Each fraction of the
gradient containing DNA-packaging intermediates from the DNA packag-
ing reaction as subsequently converted into infectious phi29 virion with
maturation components in the absence of pRNA (A), gp16 (B), or in the
presence of RNase to cleave the pRNA in the intermediates (C).
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phages separated the proteins into two groups (Guo et al.,
1987). Group one is a procapsid binding, magnesium-bind-
ing, and DNA-dependent ATPase. Group two is a DNA-
binding protein. It is interesting to find that the size of group
one proteins is larger than that of group two proteins (Table
2 in Guo et al., 1987). Subsequent studies with other phages
seem to support this distinction. For example, it has been
reported that gpNu1 of lambda binds DNA and that the
C-terminus of the DNA-dependent ATPase gp2 of phage 21
and gpA of lambda bind procapsid (Yeo and Feiss, 1995).
The size of gpNuI is smaller than gpA. The data presented
in this article suggest that pRNA is the counterpart of a
group one DNA-packaging protein; that is, pRNA is the
procapsid-binding component. pRNA might also be part of
the ATPase complex as we have demonstrated that pRNA
binds ATP (unpublished results). Overall these observations
imply that pRNA is comparable to the members in group
one, including gp17 of T4 (Manne et al., 1982), gpA of
lambda (Becker et al., 1977; Catalano et al., 1995), gp19 of
T3 and T7 (Dunn and Studier, 1983; Yamada et al., 1986),
gp2 of phage 21 (Yeo and Feiss, 1995), gp2 of P22 (Prev-
elige et al., 1990), gB of P1 (Skorupski et al., 1992), the
terminase of psiM2 (Pfister et al., 1998) or Sfi21 (Desiere et
al., 1998), gp1Y of phiC31 (Redenbach et al., 1996), UL15
of herpesvirus (Yu and Weller, 1998), IVA 2 of adenovirus
(Bett et al., 1993; Schmid and Hearing, 1997; Zhang et al.,
2001), and A32 of poxvirus (Koonin et al., 1993). However,
gp16 also contains a consensus sequence for ATP binding.
The role of gp16 in phi29 DNA packaging is still unclear.
The binding of gp16 to procapsid has not been definitively
demonstrated; one difficulty is the hydrophobic nature of
gp16. The protein is insoluble after expression and self-
aggregates after purification (Guo et al., 1986; Ibarra et al.,
2001). The result in this article might provide insight on the
function of gp16.
At least one component of a motor should act proces-
sively to keep it running constantly. Most biological motors,
including myosin, kinesin, DNA-helicase, and RNA poly-
merase, involve one factor that acts processively. In phi29,
DNA packaging involves the connector, pRNA, gp16, and
ATP. The connector cannot be the processivity factor as the
crystal structure reveals no potential ATP-binding pocket
(Guasch et al., 2002; Simpson et al., 2000). Our results
show that gp16 and pRNA are not needed to convert fin-
ished DNA-filled capsids into infectious viruses (Figs. 1, 2,
and 3). This is understandable as DNA-packaging in these
particles has been completed. The results also show that to
convert the partially filled DNA-packaging intermediates
into completed DNA-filled particles, fresh gp16 and ATP,
but not pRNA, were needed (Fig. 3). This indicates that
gp16 does not act processively during DNA translocation.
However, the six copies of pRNA that are already bound to
the motor are sufficient to complete DNA packaging. In
addition, pRNA must be actively functioning during DNA
packaging; when intermediates are treated with RNase,
DNA packaging intermediates could not be matured into
infectious virus (Fig. 3C). These data therefore suggest that
only one pRNA hexamer is needed to package one copy of
phi29 genomic DNA and that it functions continuously and
processively during DNA packaging. Furthermore, the data
also suggest that gp16 does not remain bound to the pack-
aging complex as isolated packaging intermediates require
the addition of gp16 to complete DNA encapsidation.
Materials and methods
Preparation of pRNA
RNAs were prepared as described previously (Zhang et
al., 1994). Briefly, DNA oligos were synthesized with the
desired sequences and used to produce double-stranded
DNA by PCR. The DNA products containing the T7 pro-
moter were cloned into plasmids. RNA was synthesized
with T7 RNA polymerase by run-off transcription and pu-
rified from a polyacrylamide gel. The sequences of both
plasmids and PCR products were confirmed by DNA se-
quencing.
In vitro phi29 DNA packaging
The purification of procapsids (Lee and Guo, 1995),
gp16 (Guo et al., 1986) and DNA-gp3 (Guo et al., 1986;
Ortin et al., 1971), the preparation of the tail protein (gp9),
neck proteins (gp11, gp12), the morphogenetic factor
(gp13) (Lee and Guo, 1995), and the procedure for DNA
packaging in vitro have been described previously (Guo et
al., 1986). Briefly, a quantity of 10 l of purified procapsids
was mixed with 1 1 pRNA (1 g/l) and dialyzed on a
0.025-m membrane type VS filter (Millipore Corp.)
against TBE (89 mM Tris–borate, pH 8.3, 2.5 mM EDTA)
for 15 min at ambient temperature and then dialyzed against
TMS (50 mM Tris–HCl, pH 7.8, 10 mM MgCl2, 100 mM
NaCl) for 30 min at ambient temperature. The presence of
Mg2 in TMS buffer promotes the binding of pRNA to the
procapsid. These pRNA-enriched procapsids were mixed
with 3 1 reaction buffer (10 mM ATP, 6 mM spermidine,
3 mM -mercaptoethanol in TMS), 5 1 DNA-gp3 that had
been dialyzed against TMS for 40 min at ambient temper-
ature, and 6 l DNA-gp3 packaging protein gp16 that had
been dialyzed against gp16 buffer (0.01 M Tris–Cl, pH 7.5,
and 0.04 M KCl) for 40 min on ice. These mixtures were
then incubated for 30 min at ambient temperature. DNA
packaging efficiency was verified by 5–20% sucrose gradi-
ent sedimentation (Guo et al., 1986) or agarose gel electro-
phoresis (Guo et al., 1991).
Maturation of phi29 DNA-packaging intermediates
DNA-packaging intermediates were generated by the
addition of 5% of the poorly hydrolyzable ATP analogue
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-S-ATP into the phi29 DNA packaging mixture. The in-
termediates were separated from free DNA and the finished
DNA-filled procapsids by 5–20% sucrose gradient sedimen-
tation with SW55 rotor for 35 min at 35,000 rpm. The
gradients were fractionated to separate the components that
have different sedimentation rates.
The components in each fraction of the gradient were
subsequently converted into infectious phi29 virions by the
addition of fresh components for phi29 in vitro assembly.
The complete conversion system includes pRNA, gp16,
ATP, neck protein gp11/12, and tail protein gp9. The con-
verted products of infectious virions were titrated by plating
on the bacterial host Bacillus subtilis Su44.
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